Search

Your search keyword '"Grant, Igor"' showing total 3,125 results

Search Constraints

Start Over You searched for: Author "Grant, Igor" Remove constraint Author: "Grant, Igor"
3,125 results on '"Grant, Igor"'

Search Results

1. On the issue of treating HIV in people with syndemic mental-health and substance-use disorders

2. Genetic Variations in EIF2AK3 are Associated with Neurocognitive Impairment in People Living with HIV.

3. Is gender dysphoria dysphoric? Elevated depression and anxiety in gender dysphoric and non-dysphoric homosexual and bisexual men in an HIV sample.

4. Effects of Opioid Withdrawal on Psychobiology in People Living with HIV

5. Cannabis use may attenuate neurocognitive performance deficits resulting from methamphetamine use disorder

6. Trends in Cannabis Use, Blood Pressure, and Hypertension in Middle-Aged Adults: Findings From NHANES, 2009–2018

7. Associations Between Monthly Cannabis Use and Myocardial Infarction in Middle-Aged Adults: NHANES 2009 to 2018, Corroon et al

8. A longitudinal study of cannabis use and risk for cognitive and functional decline among older adults with HIV

10. Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests.

11. Cannabis and Anxiety: A Critical Review

12. Chronic methamphetamine exposure exerts few effects on the iTat mouse model of HIV, but blocks Tat expression-induced slowed reward retrieval

13. Four-Year Trajectories of Internal Strengths and Socioemotional Support Among Middle-Aged and Older Adults with HIV

14. iTat transgenic mice exhibit hyper-locomotion in the behavioral pattern monitor after chronic exposure to methamphetamine but are unaffected by Tat expression

15. Signatures of HIV and Major Depressive Disorder in the Plasma Microbiome

16. The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition

17. Subacute myoclonic measles encephalitis – An opportunistic HIV-associated infection

18. Self-reported adverse events associated with ∆8-Tetrahydrocannabinol (Delta-8-THC) Use

19. Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV

21. Discrepancy between self-reported and objective sleep duration among dementia caregivers and noncaregivers.

22. Cognitive and Physiologic Reserve Independently Relate to Superior Neurocognitive Abilities in Adults Aging With HIV

23. Diagnostic performance of screening tools for the detection of obstructive sleep apnea in people living with HIV.

24. Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV: A Latent Growth Mixture Model

25. Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People With HIV

26. Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid

27. Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder

28. Driving Performance and Cannabis Users’ Perception of Safety

29. Longitudinal Correlates of Depressive Symptoms and Positive and Negative Affects in Family Caregivers of People With Dementia

30. Loneliness, Risky Beliefs and Intentions about Practicing Safer Sex among Methamphetamine Dependent Individuals

31. HIV Transgenic Rats Demonstrate Superior Task Acquisition and Intact Reversal Learning in the Within-Session Probabilistic Reversal Learning Task

32. Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study

33. Paresthesia Predicts Increased Risk of Distal Neuropathic Pain in Older People with HIV-Associated Sensory Polyneuropathy

34. Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV

35. The Relationships between HIV-1 Infection, History of Methamphetamine Use Disorder, and Soluble Biomarkers in Blood and Cerebrospinal Fluid.

36. Longitudinal Correlates of Depressive Symptoms and Positive and Negative Affects in Family Caregivers of People With Dementia.

37. Gut microbiota dysbiosis is associated with worse emotional states in HIV infection

38. Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral therapy

39. Telomere length is associated with HIV infection, methamphetamine use, inflammation, and comorbid disease risk

40. Both HIV and Tat expression decrease prepulse inhibition with further impairment by methamphetamine

42. Neurocognitive impairment in Spanish-speaking Latinos living with HIV in the US: Application of the neuropsychological norms for the US–Mexico border region in Spanish (NP-NUMBRS)

43. Demographically adjusted norms for the Trail Making Test in native Spanish speakers: Results from the neuropsychological norms for the US-Mexico border region in Spanish (NP-NUMBRS) project

44. Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV

45. Prior Methamphetamine Use Disorder History Does Not Impair Interoceptive Processing of Soft Touch in HIV Infection

46. Cognitive and Neuronal Link With Inflammation: A Longitudinal Study in People With and Without HIV Infection.

47. Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior

48. Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV

49. Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease

50. Depression in Individuals Coinfected with HIV and HCV Is Associated with Systematic Differences in the Gut Microbiome and Metabolome

Catalog

Books, media, physical & digital resources